Bigora Sian
SEC CIK 1799365 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PCSA | Processa Pharmaceuticals, Inc. | Chief Development Off | 7,481 | $21.4K | — | 13 | 2021-08-05 | 2026-04-30 |
Most active insiders at PCSA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Ng George K | CEO, Dir | $55.0K | — |
| 2 | SKIBSTED RUSSELL | CFO | $41.7K | — |
| 3 | Guy Wendy | Chief Administrative Off | $32.9K | — |
| 4 | Young David | Pres. Research, Development, Dir | $32.4K | — |
| 5 | Lin Patrick | Chief Business - Strategy Off | $28.5K | — |
| 6 | Bigora Sian | Chief Development Off | $21.4K | — |
| 7 | Baluch Khoso | Dir | $5,752 | — |
| 8 | Pannu Geraldine | Dir | $5,253 | — |
| 9 | Neal James R | Dir | $2,000 | — |
| 10 | Yorke Justin W | Dir | — | — |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2026-05-19 17:17 | 2026-04-30 | PCSA | Processa Pharmaceuticals, Inc. | Bigora Sian | Chief Development Off | P - Purchase | $2.71 | +1,971 | 7,481 | +36% | +$5,341 |
| 2026-05-01 16:34 | 2026-04-30 | PCSA | Processa Pharmaceuticals, Inc. | Bigora Sian | Chief Development Off | P - Purchase | $2.69 | +1,986 | 7,496 | +36% | +$5,342 | |
| 2026-04-17 16:50 | 2026-04-15 | PCSA | Processa Pharmaceuticals, Inc. | Bigora Sian | Chief Development Off | P - Purchase | $2.97 | +1,799 | 5,510 | +48% | +$5,343 | |
| 2026-04-01 17:08 | 2026-03-31 | PCSA | Processa Pharmaceuticals, Inc. | Bigora Sian | Chief Development Off | P - Purchase | $2.54 | +2,107 | 3,711 | +131% | +$5,341 | |
| D | 2026-02-04 | 2026-01-01 | PCSA | Processa Pharmaceuticals, Inc. | Bigora Sian | Chief Development Off | M - OptEx | $0.00 | +249 | 1,604 | +18% | $0 |
| 2025-04-11 | 2025-04-01 | PCSA | Processa Pharmaceuticals, Inc. | Bigora Sian | Chief Development Off | F - Tax | $0.41 | -3,311 | 33.6K | -9% | -$1,358 | |
| 2025-04-11 | 2025-04-01 | PCSA | Processa Pharmaceuticals, Inc. | Bigora Sian | Chief Development Off | M - OptEx | — | +15.1K | 36.9K | +69% | — | |
| DM | 2024-08-02 | 2024-04-05+ | PCSA | Processa Pharmaceuticals, Inc. | Bigora Sian | Chief Development Off | M - OptEx | — | +2,319 | 22.1K | +12% | — |
| DM | 2024-08-02 | 2024-04-05+ | PCSA | Processa Pharmaceuticals, Inc. | Bigora Sian | Chief Development Off | F - Tax | $2.38 | -593 | 21.5K | -3% | -$1,411 |
| D | 2024-04-12 | 2024-01-01 | PCSA | Processa Pharmaceuticals, Inc. | Bigora Sian | Chief Development Off | M - OptEx | — | +1,675 | 21.8K | +8% | — |
| D | 2024-04-12 | 2024-01-01 | PCSA | Processa Pharmaceuticals, Inc. | Bigora Sian | Chief Development Off | F - Tax | $2.79 | -368 | 21.5K | -2% | -$1,027 |
| 2022-08-09 | 2022-08-05 | PCSA | Processa Pharmaceuticals, Inc. | Bigora Sian | Chief Development Off | M - OptEx | — | +7,601 | 403.0K | +2% | — | |
| 2021-08-09 | 2021-08-05 | PCSA | Processa Pharmaceuticals, Inc. | Bigora Sian | Chief Development Off | A - Grant | — | +7,601 | 395.4K | +2% | — |
Purchase Sale Sale after option exercise All abbreviations